Michael Wolfe

Mike brings twenty years of corporate finance and life science expertise to Switch. Most recently, he was the Senior Vice President of Finance & Operations at Kezar Life Sciences, where he played at integral role in building the company from its inception to a multiple clinical program, development-stage company. Prior to Kezar’s launch in 2015, Mike served as the Head of R&D Finance at Onyx Pharmaceuticals, Inc. until its’ acquisition by Amgen, Inc. in 2013. Previously, he served in commercial finance at Mentor Corporation, a Johnson & Johnson subsidiary, pre-and post-acquisition. Mike’s career in the life sciences sector began at Amgen, Inc. where he held a number of positions of increasing responsibility within the finance organization. He began his finance career at 3Com Corporation, Inc., a leader in the manufacturing and sale of computer networking products, acquired by Hewlett Packard in 2010. Mike earned a Bachelor of Science, in Business Administration from California Polytechnic State University, San Luis Obispo.